首页> 外文期刊>Biotechnology Letters >Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus
【24h】

Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus

机译:牛O型口蹄疫病毒重组抗原表位疫苗功效与结构的相关性

获取原文
获取原文并翻译 | 示例
           

摘要

To develop recombinant epitope vaccines against foot-and-mouth disease virus (FMDV), genes coding for six recombinant proteins (rP1–rP6) consisting of different combinations of B cell and T cell epitope from VP1 capsid protein (VP1) of type O FMDV were constructed and the 3D structure of these proteins analyzed. This revealed a surface-exposed RGD sequence of B cell epitopes in all six recombinant proteins as that in VP1 of FMDV and rP1, rP2 and rP4 globally mimicked the backbone conformation of the VP1. rP1, rP2 and rP4 stimulated guinea pigs to produce higher level of neutralizing antibodies capable of protecting suckling mice against FMDV challenge. rP1 stimulated cattle to produce FMDV-neutralizing antibody. The data suggest that an efficient recombinant epitope vaccine against FMDV should share local similarities with the natural VP1 of FMDV.
机译:要开发针对口蹄疫病毒(FMDV)的重组表位疫苗,需要编码六个重组蛋白(rP1-rP6)的基因,这些蛋白由O型FMDV VP1衣壳蛋白(VP1)的B细胞和T细胞表位的不同组合组成构建并分析这些蛋白质的3D结构。这揭示了所有六种重组蛋白中B细胞表位的表面暴露RGD序列,与FMDV的VP1中的rGD1,rP2和rP4全局上模仿VP1的骨架构象一样。 rP1,rP2和rP4刺激豚鼠产生更高水平的中和抗体,能够保护乳鼠免受FMDV攻击。 rP1刺激牛产生FMDV中和抗体。数据表明,针对FMDV的高效重组抗原决定簇疫苗应与FMDV的天然VP1具有局部相似性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号